Peer-reviewedCC BY-NC-NDTranslational cancer research28 Sep 2026

Survival outcomes of radiotherapy in elderly patients with unresectable stage III hepatocellular carcinoma: a population-based retrospective cohort study

Shuai Hao¹
Jingjing Tuo²
Ziyi Xie²
Nan Lou³
Feng Li²
Ming Liu²
Xiaohui Cao²
Nan Li²

¹Department of Interventional Vascular Surgery , Aerospace Center Hospital , Beijing , ;
²Department of Oncology , Hebei Medical University Third Hospital , Shijiazhuang , ;
³Department of Pathology , Hebei Medical University Third Hospital , Shijiazhuang ,

Survival outcomes of spleen-strengthening and dampness-eliminating traditional Chinese medicine granules combined with lenvatinib for unresectable hepatocellular carcinoma: a large-sample retrospective study based on electronic medical records
Canchao Sun, Juan Xu, Tiye Sun
Frontiers in medicine19 Oct 2026Peer-reviewedCC BYFull textGeneral medicineEurope PMC
Efficacy and safety of sintilimab plus bevacizumab with or without transarterial chemoembolization for unresectable hepatocellular carcinoma: a propensity score-matched retrospective cohort study
Zizhuo Wang, Bailu Wu, Chunshu Wu +7
Frontiers in Immunology26 Oct 2026Peer-reviewedCC BY 4.0Full textImmunology General medicineCrossrefDOAJ
Conversion Surgery After HAIC-Based Combination Therapy with Targeted Therapy and Immune Checkpoint Inhibitors for Initially Unresectable Hepatocellular Carcinoma: A Retrospective Cohort Study
Xiaolong Zhang, Jun Hu, Haoming Lan +3
Journal of Hepatocellular Carcinoma27 Oct 2026Peer-reviewedCC BY-NC 4.0Full textGeneral medicinePMC
Efficacy and Safety of Sequential Radiotherapy and Immune Checkpoint Inhibitors for Advanced Hepatocellular Carcinoma: A Single-Center PSM Retrospective Cohort Study.
Huaxi Fan, Rong Yu, Guishu Wu +6
Journal of hepatocellular carcinoma28 Oct 2026Peer-reviewedCC BY-NCFull textGeneral medicineEurope PMCPMC
Early antibiotic exposure, but not late exposure, negatively affects the clinical outcomes of first-line atezolizumab plus bevacizumab in patients with unresectable hepatocellular carcinoma
Aryoung Kim, Myung Ji Goh, Byeong Geun Song +6
Scientific Reports21 Oct 2026Peer-reviewedCC BY-NC-ND 4.0Full textGeneral medicineCrossref

Cite

BibTeX

@article{hao2026survival,
  title = {{Survival outcomes of radiotherapy in elderly patients with unresectable stage III hepatocellular carcinoma: a population-based retrospective cohort study}},
  author = {Shuai Hao and Jingjing Tuo and Ziyi Xie and Nan Lou and Feng Li and Ming Liu and Xiaohui Cao and Nan Li},
  journal = {Translational cancer research},
  year = {2026},
  month = sep,
  url = {https://europepmc.org/article/PMC/PMC13743202},
  note = {CC BY-NC-ND},
}

RIS

TY  - JOUR
TI  - Survival outcomes of radiotherapy in elderly patients with unresectable stage III hepatocellular carcinoma: a population-based retrospective cohort study
AU  - Shuai Hao
AU  - Jingjing Tuo
AU  - Ziyi Xie
AU  - Nan Lou
AU  - Feng Li
AU  - Ming Liu
AU  - Xiaohui Cao
AU  - Nan Li
PY  - 2026
DA  - 2026/09/28
JO  - Translational cancer research
UR  - https://europepmc.org/article/PMC/PMC13743202
SN  - 2218-676X
ER  -

Related

Cite